Tel.: 514-340-7593
Samy Suissa, PhD
 
Director, Centre for Clinical Epidemiology, Lady Davis Institute
Professor, Departments of Epidemiology and Biostatistics and of Medicine, McGill University
 

Dr. Samy Suissa (PhD, University of Florida '82) is Director of the Centre for Clinical Epidemiology, Lady Davis Institute, and Professor, Departments of Epidemiology and Biostatistics and of Medicine, McGill University. Dr. Suissa heads the Canadian Network for Observational Drug Effect Studies (CNODES) and the McGill Pharmacoepidemiology Research Unit. He was the founding Director of the Quebec Research Network on Medication Use, funded by the FRSQ.

Dr. Suissa has chaired and served on several review committees for the
Fonds de la recherche en santé du Québec (FRSQ) and the Canadian Institutes of Health Research (CIHR), including chairing the FRSQ Chercheur-National awards committee. He serves on the External Advisory Board of PROTECT, the drug safety consortium formed by the European Innovative Medicines Initiative (IMI). Dr. Suissa is on the Editorial Board of the European Respiratory Journal, Lancet Respiratory Medicine, COPD -The Journal of Chronic Obstructive Pulmonary Disease, and Pharmacoepidemiology and Drug Safety. He is a Section Head editor in statistical methodologies and health informatics for F-1000 Medicine. He served as Associate Editor of the Journal of Disease Management and Health Outcomes, as well as Treatments in Respiratory Medicine. He was an elected member of the boards of directors of the International Society of Pharmacoepidemiology and of the Canadian Association for Pharmaceutical Therapeutics.

Dr. Suissa has received
Chercheur-Boursier awards from the FRSQ, a Senior Scientist award from the Medical Research Council of Canada (MRC) and the Distinguished Scientist award from CIHR. He is a fellow of the Canadian Academy of Health Science. He was the recipient of the FC Donders Professor Award from the Universiteit Utrecht, Netherlands, and currently holds a James McGill Professor Chair from McGill University.

Major Research Activities

Dr. Suissa’s research is in pharmacoepidemiology which involves studying the risks and benefits of medications at the within the population at large. He specializes in the exploitation of existing computerized health databases to rapidly evaluate these risks. He has developed, and published extensively on, new methods of data analysis and study design that allow more rapid and accurate assessments of drug safety. He has conducted pharmacoepidemiological studies of several medications used for the treatment of chronic diseases, including asthma and COPD, diabetes, cardiovascular and rheumatic diseases, and women’s health issues. He has lectured extensively throughout the world, and is the author of more than 360 peer-reviewed research papers published in scientific journals.

Recent Publications
 
Suissa S, Patenaude V, Lapi F, Ernst P. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 2013;68(11):1029-36.

Suissa S, Moodie EE, Dell’Aniello S. Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores. Pharmacoepidemiol Drug Saf 2017;26(4):459-468.

Suissa S, Dell’Aniello S, Ernst P. Long-acting bronchodilator initiation in COPD and the risk of adverse cardio-pulmonary events: A population-based comparative safety study. Chest 2017;151(1)60-67.

Snapshot

Dr. Suissa is an internationally recognized scientist in the field of pharmacoepidemiology, and is frequently invited to speak at meetings and conferences.

Dr. Suissa has received several research scholar awards from FRSQ, MRC, and CIHR over the past 25 years, as well as the prestigious FC Donders Award from the Universiteit Utrecht.

Dr. Suissa has published extensive studies on the risks and benefits of commonly used medications for the treatment of several chronic diseases.

 
 
Important Links

 
Support research at the Lady Davis Institute - Jewish General Hospital